Results 201 to 210 of about 38,260 (246)
Some of the next articles are maybe not open access.
Treatment of Chemotherapy-Induced Nausea and Vomiting
Journal of Gastrointestinal Cancer, 2012Recent improvements in medical oncology include both development of anticancer and supportive therapy. Serotonin receptor antagonists were introduced in clinical practice 20 years ago. Since then, the prevention and treatment of chemotherapy-induced nausea and vomiting allows continuing efficacious chemotherapy that earlier had to be stopped sometimes ...
Hanane, Inrhaoun +4 more
openaire +2 more sources
Management of chemotherapy-induced nausea and vomiting
British Journal of Hospital Medicine, 2006Chemotherapy-induced nausea and vomiting are symptoms that cause major concern to oncology patients. This article explores the types of nausea and vomiting in the context of chemotherapy, and discusses their pathogenesis and management.
openaire +3 more sources
Chemotherapy-induced nausea and vomiting
Postgraduate medicinePreview Modem chemotherapy provides meaningful palliation for cancer and even cures some forms. Unfortunately, it causes numerous adverse reactions. Nausea and vomiting are the most feared and debilitating for many patients; in fact, some patients refuse potentially beneficial chemotherapy to avoid these side effects.
Syed, Bilgrami, Barbara G, Fallon
openaire +3 more sources
Aprepitant for Chemotherapy-Induced Nausea and Vomiting
Clinical Journal of Oncology Nursing, 2004Although the development of serotonin receptor antagonists has greatly improved treatment for chemotherapy-induced nausea and vomiting, patients receiving chemotherapy continue to experience this troublesome side effect. On March 26, 2003, the U.S. Food and Drug Administration approved aprepitant (Emend, Merck & Co., Inc., Whitehouse Station, NJ) for ...
openaire +2 more sources
Rolapitant: A Review in Chemotherapy-Induced Nausea and Vomiting
Drugs, 2017Oral rolapitant (Varubi™; Varuby®), a long-acting neurokinin-1 (NK1) receptor antagonist (RA), is indicated in the USA and EU as part of an antiemetic regimen to prevent delayed chemotherapy-induced nausea and vomiting (CINV) in adults receiving highly or moderately emetogenic chemotherapy (HEC or MEC).
Young-A, Heo, Emma D, Deeks
openaire +2 more sources
Control of cancer chemotherapy-induced nausea and vomiting
Cancer, 1984With increasingly effective cancer chemotherapy, the control of chemotherapy-induced nausea and vomiting has become more important. These unpleasant side effects can be so severe that patients delay or stop potentially curative therapy. Phenothiazines and butyrophenones have been the mainstays of most antiemetic therapy but unfortunately have only ...
H J, Eyre, J H, Ward
openaire +2 more sources
Chemotherapy Induced Nausea and Vomiting
2017By the end of this chapter you will be able to: Describe the definitions related to chemotherapy-induced nausea and vomiting. Describe the risk factors. List differential diagnoses for nausea and vomiting. Describe the emetogenic risk of the various chemotherapeutic agents.
Daniela Cristina Stefan, Mhamed Harif
openaire +1 more source
Effectively managing chemotherapy—induced nausea and vomiting
British Journal of Nursing, 2011This article examines the unpleasant side effect of chemotherapy-induced nausea and vomiting (CINV). What was once the main reason for withdrawing from treatment is now much more tolerable owing to the advent of modern antiemetics. However, because of the improvements in these antiemetics, the focus on CINV appears to have lapsed.
Janice, Middleton, Elaine, Lennan
openaire +2 more sources
The cost of chemotherapy-induced nausea and vomiting in Italy
Supportive Care in Cancer, 2006The aim of this paper is to analyze the costs of chemotherapy-induced nausea and vomiting (CINV) in Italy.In this prospective observational study at seven public oncology centers, incidence and intensity of CINV daily for 8 days after chemotherapy in consecutive patients receiving cisplatin-containing chemotherapy were recorded.
Enzo, Ballatori +10 more
openaire +2 more sources
Palonosetron for the prevention of chemotherapy-induced nausea and vomiting
Expert Review of Anticancer Therapy, 2013Chemotherapy-induced nausea and vomiting (CINV) remains both a feared side effect of cancer treatment and a focus of many supportive care initiatives/guidelines. The class of medications known as serotonin receptor antagonists (5-HT3RAs) are integral in the prevention of CINV from both moderately and highly emetogenic chemotherapy. Palonosetron (ALOXI(®
Sherry, Mori-Vogt, Marlo, Blazer
openaire +2 more sources